These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

854 related items for PubMed ID: 18418427

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antiplatelet agents sarpogrelate and cilostazol affect experimentally-induced ventricular arrhythmias and mortality.
    Barta J, Sanganalmath SK, Kumamoto H, Takeda N, Edes I, Dhalla NS.
    Cardiovasc Toxicol; 2008; 8(3):127-35. PubMed ID: 18751928
    [Abstract] [Full Text] [Related]

  • 3. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F, Thomas W, Way K, Tzanidis A, Kompa A, Lewis D, Itescu S, Krum H.
    J Am Coll Cardiol; 2004 Oct 19; 44(8):1679-89. PubMed ID: 15489104
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
    Henderson KK, Danzi S, Paul JT, Leya G, Klein I, Samarel AM.
    Circ Heart Fail; 2009 May 19; 2(3):243-52. PubMed ID: 19808346
    [Abstract] [Full Text] [Related]

  • 8. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
    Kompa AR, See F, Lewis DA, Adrahtas A, Cantwell DM, Wang BH, Krum H.
    J Pharmacol Exp Ther; 2008 Jun 19; 325(3):741-50. PubMed ID: 18334667
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
    Ellmers LJ, Scott NJ, Cameron VA, Richards AM, Rademaker MT.
    J Cardiovasc Pharmacol; 2015 Mar 19; 65(3):269-75. PubMed ID: 25658462
    [Abstract] [Full Text] [Related]

  • 11. Effects of treatment with a 5-HT4 receptor antagonist in heart failure.
    Birkeland JA, Sjaastad I, Brattelid T, Qvigstad E, Moberg ER, Krobert KA, Bjørnerheim R, Skomedal T, Sejersted OM, Osnes JB, Levy FO.
    Br J Pharmacol; 2007 Jan 19; 150(2):143-52. PubMed ID: 17160012
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C.
    Circulation; 2004 Apr 06; 109(13):1674-9. PubMed ID: 14981003
    [Abstract] [Full Text] [Related]

  • 14. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation.
    Thai H, Guarraia D, Johnson N, Goldman S, Gaballa MA.
    J Cardiovasc Pharmacol; 2007 Dec 06; 50(6):703-7. PubMed ID: 18091589
    [Abstract] [Full Text] [Related]

  • 15. Altered melusin pathways involved in cardiac remodeling following acute myocardial infarction.
    Gu R, Zheng D, Bai J, Xie J, Dai Q, Xu B.
    Cardiovasc Pathol; 2012 Dec 06; 21(2):105-11. PubMed ID: 21546274
    [Abstract] [Full Text] [Related]

  • 16. Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling.
    Villarreal FJ, Griffin M, Omens J, Dillmann W, Nguyen J, Covell J.
    Circulation; 2003 Sep 23; 108(12):1487-92. PubMed ID: 12952845
    [Abstract] [Full Text] [Related]

  • 17. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
    Milliez P, Messaoudi S, Nehme J, Rodriguez C, Samuel JL, Delcayre C.
    Am J Physiol Heart Circ Physiol; 2009 Feb 23; 296(2):H435-41. PubMed ID: 19074674
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Wide-spread myocardial remodeling after acute myocardial infarction in rat. Features for heart failure progression.
    Krzemiński TF, Nozyński JK, Grzyb J, Porc M.
    Vascul Pharmacol; 2008 Feb 23; 48(2-3):100-8. PubMed ID: 18276196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.